Sino Biological Newly Launched A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529) Beijing, China, December 6th, 2021 – Sino Biological, Inc. (https://www.sinobiological.com, SHE: ...

DUBLIN--(BUSINESS WIRE)--The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights & Forecast with Potential Impact of COVID-19 (2023-2027)" report has ...

China, August 16, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company which provides biological research reagents and related technical contract research ...

Sino Biological, Inc. announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus, which quickly raised concerns ...

Boston, Oct. 30, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Biological and Medical Imaging Reagents: Global Markets” is projected to grow from $26.6 billion in 2025 to ...

Dublin, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The "Biological and Medical Imaging Reagents: Global Markets" has been added to ResearchAndMarkets.com's offering. The global biological and medical imaging ...

Sino Biological, a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange ...

RESEARCH TRIANGLE, N.C.--(BUSINESS WIRE)--JAGGAER, the global leader in Autonomous Commerce, is collaborating with CiteAb, a UK-based provider of high-quality life science data, to enable researchers ...

Scientists are constantly looking for new and better ways of seeing through biological tissue, in order to see cells within it that have been marked with dyes, proteins or other substances. While ...

The Global biological imaging reagent market is predicted to rise at a CAGR of 7.86% over the forecast period of 2018- 2026. The key factors driving market growth include the growing demand for ...

GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today that Beijing- and Philadelphia-based Sino Biological, ...

(MENAFN- GlobeNewsWire - Nasdaq) Emerging opportunities in biological and medical imaging reagents include rising diagnostic needs, AI integration, multiplex technologies, and nanotechnology ...